Treatment
Chlamydia can be treated with a variety of antibiotics, including azithromycin, tetracyclines, quinolones, and erythromycin. Erythromycin and azithromycin are safe in pregnant women.
Both sexual partners must be treated to prevent passing the infection back and forth between them, even though both may not have symptoms.
Since gonorrhea often occurs along with chlamydia, treatment for gonorrhea is often given at the same time.
Prognosis (Expectations)
Antibiotic treatment is usually successful. Reinfection may occur if you do not take your medicine as directed, or if your sexual partner is not treated.
Complications
Chlamydia infections in women may lead to inflammation of the cervix.
An untreated chlamydia infection may spread to the uterus or the fallopian tubes, causing salpingitis or pelvic inflammatory disease. These conditions can lead to infertility and increase the risk of ectopic pregnancy.
If a women is infected with chlamydia while pregnant, the infection can cause premature labor and delivery. It may also cause infection in the uterus after delivery (late postpartum endometritis). In addition, the infant may develop chlamydia-related conjunctivitis (eye infection) and pneumonia.
Calling Your Health Care Provider
Call for an appointment with your health care provider if symptoms of chlamydia occur.
-
Chlamydia infections in women : Overview, Causes, & Risk Factors
-
Chlamydia infections in women : Symptoms & Signs, Diagnosis & Tests
-
Chlamydia infections in women : Treatment
Review Date : 5/12/2008
Reviewed By : Linda Vorvick, MD, Seattle Site Coordinator, Lecturer, Pathophysiology, MEDEX Northwest Division of Physician Assistant Studies, University of Washington School of Medicine; Susan Storck, MD, FACOG, Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Redmond, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.